The ratings
The panel's grade, asset by asset.
Six pillars - macro fit, theme tailwind, valuation, quality, technical timing, risk - a grade from A to E, and a detractor that attacks every case before publication. Here are four real cards, good and bad grades included: judge the method on the evidence.
Real cards, frozen at their publication date - in the app, every rating is recomputed on demand, dated and sourced. Information, never a buy order.
NOVO · DK0062498333 · Stock · European champions
In plain termsNovo Nordisk is a world-class obesity and diabetes company trading at its cheapest valuation in a decade, but its profits are shrinking right now and it is losing its US lead to Eli Lilly - cheap for real reasons. The chart just broke down, so the panel takes only a small starter and waits for proof rather than buying in.
The six pillars
Counter-argument - the Detractor
« The low P/E is a value trap: forward P/E (13.5) exceeds trailing (11.2) because forward EPS is falling ~21%, FY sales are guided negative (0 to -6% cc), and a legacy-injectable patent cliff plus US pricing pressure are structural - the discount to Novo's own 25-40x history may be permanent, not an opportunity. »
NVDA · US67066G1040 · Stock · Semiconductors · Artificial intelligence
In plain termsNVIDIA is the best-positioned business in the AI build-out and looks cheap on next year's earnings - but only if those earnings nearly double as expected, and the stock has run back near its record just before make-or-break results. Don't chase it here; keep the ammunition for a pullback toward 205 or lower.
The six pillars
Counter-argument - the Detractor
« The forward-P/E discount (17.6 vs 37 sector) rests entirely on forward EPS priced at ~2x trailing (12.82 vs 6.56); a single hyperscaler capex cut or a full China H200 block collapses that growth and re-exposes a 34x trailing / 27.9x P/B / 21.5x P/S multiple on peak-cycle earnings - with the stock chased to within 5% of its record 12 days before a binary print. »
KER · FR0000121485 · Stock · French blue chips · Luxury
In plain termsKering (Gucci's owner) is early in a turnaround: sales just stopped falling and margins stopped shrinking, but the business is still weak, carries a lot of debt, and the share price already assumes the fix works. The panel waits for proof rather than paying up now.
The six pillars
Counter-argument - the Detractor
« The 'turnaround' is a -2% Gucci comp dressed up as momentum: revenue is still shrinking, net margin is negative on a TTM basis, leverage is 4.43x on trough EBITDA, and a fwd P/E of 27x already prices the recovery - a value trap if China luxury does not re-accelerate. »
TSLA · US88160R1014 · Stock · US megacap tech
In plain termsTesla is a great story priced like a miracle: it trades at over 150 times next year's earnings while its car-making profit has collapsed to almost nothing. The robotaxi dream might justify it one day, but today the stock is in a clear downtrend with no catalyst until October - there is no reason to chase it.
The six pillars
Counter-argument - the Detractor
« Robotaxi/FSD + Optimus is genuine unpriced optionality on a net-cash balance sheet with recovering FCF; scoring TSLA as a margin-impaired carmaker is the exact mistake bears made all the way up - a demonstrated monetization step re-rates it in one print. »
How to read a grade
A scale that can say no.
A solid case today - the pillars converge, the reservations are minor.
A real but conditional thesis - price, cycle or volatility impose strict conditions.
Structurally unfavourable - fees, product construction or a conflict of interest work against you.
Every grade is the result of a debate: the analysts defend the case, the Detractor breaks it, and the card publishes both. The full methodology is published - a grade informs your decision, it does not replace it.
Your assets, put through the same sieve.
In the beta, you ask for the grade of any asset - fund, stock, crypto - and the panel builds it before your eyes, with sources.